What happens during a C&P exam for Aplastic Anemia?

Blood-disorder ratings turn on objective measures - platelet counts, transfusion frequency, and the intensity of treatment (38 CFR 4.117). Bring your recent CBC and lab results. For immune thrombocytopenia (DC 7705), the rating is driven by your platelet count and whether you require chemotherapy or immunosuppressive therapy - document both.

← All Condition Guides

CLAIMRECON INTEL

Aplastic Anemia

Q: What are the VA rating percentages for Aplastic Anemia?

Aplastic Anemia (DC 7716) is rated at 100%, 60%, 30% under 38 CFR § 4.117, DC 7716 (Aplastic anemia). Requiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period

Q: What rates 100% for Aplastic Anemia under 38 CFR § 4.117, DC 7716 (Aplastic anemia)?

Under 38 CFR § 4.117, DC 7716 (Aplastic anemia) (DC 7716), a 100% rating for Aplastic Anemia requires: Requiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period

Q: What rates 60% for Aplastic Anemia under 38 CFR § 4.117, DC 7716 (Aplastic anemia)?

Under 38 CFR § 4.117, DC 7716 (Aplastic anemia) (DC 7716), a 60% rating for Aplastic Anemia requires: Requiring transfusion of platelets or red cells, on average, at least once every three months per 12-month period; or infections recurring, on average, at least once every three months per 12-month period; or using continuous therapy with immunosuppressive agent or newer platelet stimulating factors

Q: What rates 30% for Aplastic Anemia under 38 CFR § 4.117, DC 7716 (Aplastic anemia)?

Under 38 CFR § 4.117, DC 7716 (Aplastic anemia) (DC 7716), a 30% rating for Aplastic Anemia requires: Requiring transfusion of platelets or red cells, on average, at least once per 12-month period; or infections recurring, on average, at least once per 12-month period

Q: What evidence do I need for a Aplastic Anemia VA claim?

Key evidence for a Aplastic Anemia claim includes: Recent CBC and lab reports showing platelet count, hemoglobin, and neutrophil/ANC values; Transfusion records showing the number of platelet or red-cell transfusions per 12 months; A dated log of painful (vaso-occlusive) crises (sickle cell anemia); Hematology/oncology records documenting active disease or treatment-phase dates; Documentation of treatment intensity (continuous medication, immunosuppressive therapy, growth factors, or chemotherapy). All evidence should document both the condition and its impact on daily functioning.

DC 771638 C.F.R. § 4.117

Diagnostic Code

DC 7716

38 C.F.R. § 4.117

Rating Range

30–100%

3 severity tiers

Source

Verified

38 C.F.R. § 4.117

Aplastic Anemia is rated by the U.S. Department of Veterans Affairs under DC 7716 of 38 CFR § 4.117, DC 7716 (Aplastic anemia) across 3 severity tiers (100% / 60% / 30%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Rare condition where the bone marrow fails to produce enough blood cells. Causes fatigue, frequent infections, and uncontrolled bleeding. Can be triggered by chemical exposure, radiation, medications, or autoimmune disease.

Rating Criteria

100%

Requiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period

60%

Requiring transfusion of platelets or red cells, on average, at least once every three months per 12-month period; or infections recurring, on average, at least once every three months per 12-month period; or using continuous therapy with immunosuppressive agent or newer platelet stimulating factors

30%

Requiring transfusion of platelets or red cells, on average, at least once per 12-month period; or infections recurring, on average, at least once per 12-month period

Key Evidence

—Recent CBC and lab reports showing platelet count, hemoglobin, and neutrophil/ANC values

—Transfusion records showing the number of platelet or red-cell transfusions per 12 months

—A dated log of painful (vaso-occlusive) crises (sickle cell anemia)

—Hematology/oncology records documenting active disease or treatment-phase dates

—Documentation of treatment intensity (continuous medication, immunosuppressive therapy, growth factors, or chemotherapy)

—Bone marrow biopsy or other diagnostic reports confirming the condition

C&P Exam Tips

1Blood-disorder ratings turn on objective measures - platelet counts, transfusion frequency, and the intensity of treatment (38 CFR 4.117). Bring your recent CBC and lab results.

2For immune thrombocytopenia (DC 7705), the rating is driven by your platelet count and whether you require chemotherapy or immunosuppressive therapy - document both.

3For anemias requiring transfusion (for example, aplastic anemia, myelodysplastic syndromes), count how many transfusions of platelets or red cells you need per 12 months - that frequency sets the level.

4For sickle cell anemia (DC 7714), the rating counts painful (vaso-occlusive) crises per 12 months and the level of work you can still do - keep a dated log of every crisis.

5Active disease or an active treatment phase (chemotherapy) often supports a 100% evaluation for blood cancers - make sure your treatment dates are on the record.

6Report how fatigue, infections, or bleeding affect work and daily activity, and list all medications including any continuous or immunosuppressive therapy.

More in Hematologic & Lymphatic

Chronic B-Cell Leukemia Deep Vein Thrombosis / Chronic Venous Insufficiency Hemolytic Anemia Hemophilia Hodgkin's Disease (Hodgkin's Lymphoma)Hypercoagulable States (Thrombophilia)Iron Deficiency Anemia (Generic — Rated by Analogy)Leukemia All Hematologic & Lymphatic conditions →All conditions →

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.117 (Hemic and lymphatic systems). Source verified 2026-06-05 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.117 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIMRECON 2026

LOADING